1. Identification of Immune-Related Genes for Risk Stratification in Multiple Myeloma Based on Whole Bone Marrow Gene Expression Profiling
   Qiang-Sheng Wang et al, 2022, Frontiers in Genetics CrossRef
2. The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells
   Ida Steiro et al, 2022, Oncotarget CrossRef
3. Updates to the drug‐resistant mechanism of proteasome inhibitors in multiple myeloma
   Yang Bai et al, 2021, Asia-Pacific Journal of Clinical Oncology CrossRef
4. Can Targeting Hypoxia-Mediated Acidification of the Bone Marrow Microenvironment Kill Myeloma Tumor Cells?
   Gilberto Gastelum et al, 2021, Frontiers in Oncology CrossRef
5. Identification of key genes and miRNA-mRNA regulatory networks associated with bone marrow immune microenvironment regulations in multiple myeloma by integrative bioinformatics analysis
   Niluopaer Tuerxun et al, 2022, Hematology CrossRef
6. Ex Vivo Models Simulating the Bone Marrow Environment and Predicting Response to Therapy in Multiple Myeloma
   Konstantinos Papadimitriou et al, 2020, Cancers CrossRef
7. FABP5, a Novel Immune-Related mRNA Prognostic Marker and a Target of Immunotherapy for Multiple Myeloma
   Haipeng Jia et al, 2021, Frontiers in Medicine CrossRef
8. Identification of the Cysteine Protease Legumain as a Potential Chronic Hypoxia-Specific Multiple Myeloma Target Gene
   Ada-Sophia Clees et al, 2022, Cells CrossRef
9. Treatment Strategies for Multiple Myeloma Treatment and the Role of High-Throughput Screening for Precision Cancer Therapy
   Thudzelani Takalani Austin Malise et al, 2023, Cell Biology and Translational Medicine, Volume 20 CrossRef
10. Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma
    Annette Gilchrist et al, 2022, Frontiers in Endocrinology CrossRef